Please make a note that the complete submission of your eLetter should include: 1. Providing all requested information at length of the eLetter submission form below, and  2. Execution of the submission of the completed form.  Once your eLetter submission is executed, you will see the confirmation page and will receive an e.mail confirming your submission.

eLetter submission form navigation menu:

eLETTER TERMS

SUBMITTER INFO

AUTHORS INFO

TITLE AND TEXT

ACCEPT DISCLAIMERS

SUBMIT FORM

Please note:  All applicable fields require your information.

1. eLetter submitting author information 

eLetter submitting author information box

	First name:		Middle_Initial:
	Last name:
	Institution:
	Department:
	Street:		City:
	State/Province:		Postal Code:
	Country:		Tel:
	Email:		Fax:

Please check 'eLetter submitter information' above and proceed to the next section.

2. Authors and affiliations 

eLetter authors information box

Other authors and their affiliation: Corresponding author name and e.mail:

Please check 'Other authors' info (if any) above and proceed to the next section.

3. Your eLetter information 

eLetter information box

Provide the citation for article under discussion: Enter carefully (copy/paste, or type in; see DJ Noteworthy page or PubMed for details). eLetter title: Enter carefully (copy/paste, or type in). This information will be used by the search engine

eLetter text: Enter carefully (copy/paste, or type in). Please provide ten key words at the end of the text. No more then 1000-1500 words. Please provide URL web addresses for your citations.

Please check 'eLetter title and text' above and proceed to the next section.

4. Disclaimers

Disclaimers and submission terms acceptance box

eLETTER DISCLAIMERS & SUBMISSION TERMS ACCEPTANCE Please note: We will not consider your eLetter unless you confirm all items in this box A. I (as submitting author) confirm the following: All listed authors have agreed with this eLetter submission to The Doping Journal. B. The authors confirm the following item: All listed authors have agreed with the Copyright and License agreement of the Doping Journal. Please re-confirm by typing ' we accept ' that by submitting a eLetter, all authors accept The Doping Journal Copyright and License agreement: C. The authors have read the guidance note on competing interests and have:  Decided that they have no competing interests Listed their competing interests at the end of the letter

Please check 'Disclaimers' section above and proceed to the next section.

5. Submit eLetter 

Before you execute your eLetter submission, please preview all entries and double check all fields. Be sure that everything is in order. Once you press the 'Submit' button, you will no longer be able to make revisions to the submitted letter.

You may find helpful to use document navigation menu below to fast access different sections of the form for checking the form fields.

Select 'submit eLetter' button above if everything looks correct. When your eLetter is submitted, you will see the confirmation page. You will also receive an automatic email acknowledgement of your eLetter submission. In case this automatic email to you bounces, your eLetter will not be published.

Use 'Clear the form' button to clear all eLetter submission form entries (in order to start the eLetter submission again, for example).
 

Doping Journal eLetters terms and submission advise:

Guidelines:
eLetters should be up to 1000 words. All statements should be supported with full references when appropriate. We will appreciate your providing us with the URL links for your citations. Our simple instructions will advise you on how to accomplish this routine easy task. WEB+ citations welcome.

Disclaimer:
We intend to publish within two weeks eLetters that contribute substantially to any article on the subject of doping science. To avoid points that have already been made, please read other DJ eLetters (if any) before posting your own. All submission fields (including the competing interest statement) are required to contribute eLetter. Competing interest statement will be published with the response.

Especially important are correct email addresses. Why? Your email address is essential to execute your eLetter submission. Upon your submission you will receive an automatic email acknowledgement of your eLetter submission. In case this automatic email to you bounces, your eLetter will not be considered/published.

Competing Interest and Conflict of Interest:
If you (or any of your co-authors) have any financial or professional affiliations that may be perceived as a competing interest or as a conflict of interest in responding to the article on the subject of the doping science, please describe those affiliations after your eLetter text. Please read our competing interest note.

In case authors feel they do not have competing interests it is best to make such a statement at the end of the letter in addition to the tick. When authors tick 'no competing interest' choice without a statement at the end of the document we will add the statement 'competing interests: none declared'.

You may find helpful to see other related documents:
Advice to Authors | Uniform Requirements | Our technical requirements for manuscripts | About the Journal